AGT and Hyperbilirubinemia: The antihypertensive activity of a moderate hyperbilirubinemia is related to an increase in NO bioavailability due to the reduction of AngII-dependent superoxide generation by endothelial cells (Pflueger et al., 2005; Vera et al., 2009).